Aether Bio is a Biotech company based in Menlo Park, California. It has raised $49M in total funding. Latest round: Series A.
Aether Bio funding overview
Aether Bio is a Biotech company based in Menlo Park, California. Aether Bio has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2023. The round record for Aether Bio runs through 2023; nothing later has been disclosed. Investors on record include Ascension Ventures, GE Ventures, Highland Capital Partners, Northpond Ventures, Social Capital, Tiger Global Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Aether Bio at a glance
Total raised
$49M
Latest round
Series A
Latest round date
August 2023
Industry
Biotech
Headquarters
Menlo Park, California
Notable investors
Ascension Ventures, GE Ventures, Highland Capital Partners, Northpond Ventures, Social Capital, Tiger Global Management, Unless, Khosla Ventures
Frequently asked about Aether Bio funding
How much has Aether Bio raised?
Aether Bio has raised $49M in total disclosed funding across the rounds on record.
Who has invested in Aether Bio?
Ascension Ventures, GE Ventures, Highland Capital Partners, Northpond Ventures, Social Capital, Tiger Global Management are named among the investors backing Aether Bio.
What was the latest Aether Bio funding round?
The most recent disclosed round is a Series A, announced in August 2023.
Where is Aether Bio based?
Aether Bio is based in Menlo Park, California.
What sector does Aether Bio operate in?
Aether Bio is tracked under Biotech from Menlo Park, California, with $49M in disclosed funding.
When did Aether Bio last raise?
The last disclosed Aether Bio round closed in August 2023 at Series A.
We update the Aether Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Menlo Park and their backers are listed below.
